Investigation of the efficacy of Tarantula cubensis extract (Theranekron D6) in the treatment of subclinical and clinical mastitis in dairy cows

The aim of this study was to investigate the effects of the use of Theranekron alone or in combination with intramammary antibiotic therapy for the treatment of subclinical and clinical mastitis on the recovery rate from mastitis. The study material was composed of 177 mammary lobes of 63 Holstein cows with subclinical (groups S1 and S2) and clinical mastitis (groups C1, C2, C3, and C4). In all of the treatment groups, excluding group S2, the California mastitis test scores were determined to have decreased after treatment (P < 0.05). In groups C1, C2, C3, and C4, which were treated for clinical mastitis, the somatic cell count (SCC) values were observed to have decreased. The decrease in SCC values was statistically significant except in group C2 (P < 0.01). While the SCC values were observed to have decreased in group S1 (P > 0.05), which was treated with Theranekron alone, the same values were found to have increased in group S2, which was maintained for control purposes (P < 0.05). This study demonstrated that Theranekron D6 could be used as an alternative therapeutic for the treatment of clinical and subclinical mastitis, as it is authorized for the use in cattle with a withdrawal period of zero hours for meat and milk.

Investigation of the efficacy of Tarantula cubensis extract (Theranekron D6) in the treatment of subclinical and clinical mastitis in dairy cows

The aim of this study was to investigate the effects of the use of Theranekron alone or in combination with intramammary antibiotic therapy for the treatment of subclinical and clinical mastitis on the recovery rate from mastitis. The study material was composed of 177 mammary lobes of 63 Holstein cows with subclinical (groups S1 and S2) and clinical mastitis (groups C1, C2, C3, and C4). In all of the treatment groups, excluding group S2, the California mastitis test scores were determined to have decreased after treatment (P < 0.05). In groups C1, C2, C3, and C4, which were treated for clinical mastitis, the somatic cell count (SCC) values were observed to have decreased. The decrease in SCC values was statistically significant except in group C2 (P < 0.01). While the SCC values were observed to have decreased in group S1 (P > 0.05), which was treated with Theranekron alone, the same values were found to have increased in group S2, which was maintained for control purposes (P < 0.05). This study demonstrated that Theranekron D6 could be used as an alternative therapeutic for the treatment of clinical and subclinical mastitis, as it is authorized for the use in cattle with a withdrawal period of zero hours for meat and milk.

___

  • Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003; 34: 475–491.
  • Janzen JJ. Economic losses resulting from mastitis. A review. J Dairy Sci 1970; 53: 1151–1161.
  • Sandholm M, Matilla T. Biochemical aspects of bovine mastitis. Isr J Vet Med 1986; 42: 405–415.
  • Sears PM, Heider LE. Detection of mastitis. Vet Clin North Am Large Anim Pract 1981; 3: 327–346.
  • de Haas Y, Barkema HW, Schukken YF, Veerkamp RF. Associations between somatic cell count patterns and the incidence of clinical mastitis. Prev Vet Med 2005; 67: 55–68.
  • Ziv G. Treatment of peracute and acute mastitis. Vet Clin North Am Food Anim Pract 1992; 8: 1–15.
  • Jones GF, Ward GE. Cause, occurrence, and clinical signs of mastitis and anorexia in cows in a Wisconsin study. J Am Vet Med Assoc 1989; 195: 1108–1113.
  • Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical Veterinary Microbiology. London, UK: Wolfe Publishing; 1994.
  • Erskine RJ, Kirk JH, Tyler JW, DeGraves FJ. Advances in the therapy for mastitis. Vet Clin North Am Food Animal Pract 1993; 9: 499–517.
  • Nair MK, Joy J, Vasudevan P, Hinckley L, Hoagland TA, Venkitanarayanan KS. Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci 2005; 88: 3488–3495.
  • Diarra MS, Petitclerc D, Lacasse P. Response of Staphylococcus aureus isolates from bovine mastitis to exogenous iron sources. J Dairy Sci 2002; 85: 2141–2148.
  • Oldham ER, Daley MJ. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic. J Dairy Sci 1991; 74: 4175–4182.
  • Hillerton JE, Semmens JE. Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs J Dairy Sci. 1999; 82: 93–98.
  • Ma J, Cocchiaro J, Lee JC. Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin. J Dairy Sci 2004; 87: 178–182.
  • Gürbulak K, Kılıçarslan MR. İmmunostimulant etkili Levamizol’ün sığır mastitis, metritis ve fötal ölüm üzerine etkisi. İÜ Vet Fak Derg 2004; 30: 35–46 (in Turkish).
  • Snowden JM. Wound contraction. A quantitative interpretation. Aust J Exp Biol Med Sci 1981; 59: 203–217.
  • Mezger J. Prospected homeopathic pharmaceutical product device. Australas Nurses 1977; 2: 1418–1421.
  • Stampa S. A field trial comparing the efficacy of sulfamonomethoxine, penicillin, and tarantula poison in the treatment of pododermatitis circumspecta of cattle. J S Afr Vet Assoc 1986; 57: 91–93.
  • Gültiken N, Vural MR. The effects of Tarantula cubensis extract applied in pre and postoperatative period of canine mammary tumors JIVS 2007; 2: 13–23.
  • Albay MK, Şahinduran Ş, Kale M, Karakurum MÇ, Sezer K. Influence of Tarantula cubensis extract on the treatment of the oral lesions in cattle with bluetongue disease. Kafkas Univ Vet Fak Derg 2010; 16: 593–596.
  • Lotfollahzadeh S, Alizadeh MR, Mohri M, Mokhber Dezfouli MR. The therapeutic effect of Tarentula cubensis extract (Theranekron®) in foot-and-mouth disease in cattle: a randomised trial in an endemic setting. Homeopathy 2012; 101: 159–164.
  • Gürbulak K, Yıldız S, Beytut E, Bademkıran S, Pancarcı SM, Kaçar C, Güngör Ö, Kaya D, Oral H. Investigation of the efficacy of UT Forte and Theranekron for the treatment of retained placenta in cows. Indian Vet J 2010; 87: 1267–1269.
  • McDougall S, Agnew KE, Cursons R, Hou XX, Compton CRW. Parenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide in dairy cattle. J Dairy Sci 2007; 90: 779–789.
  • Koneman EM, Allen SD, Dovell VR, Sommers HM, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology. 5th Edition. Philadelphia, PA, USA: JP Lippincott Company; 1997.
  • Hintze J. NCSS 9. NCSS, LLC. Kaysville, Utah, USA. (www. ncss.com.). 2013.
  • Schukken YH, Grommers FJ, Van de Geer D, Erb HN, Brand A. Risk factors for clinical mastitis in herds with a low bulk milk somatic cell count. 1. Data and risk factors for all cases. J Dairy Sci 1990; 73: 3463–3471.
  • Erer H, Ateş M, Kıran MM, Çiftçi MK, Kaya O. İneklerde mastitislerin patolojik ve bakteriyolojik incelenmesi. Vet Bil Derg 1996; 12: 123–133 (in Turkish).
Turkish Journal of Veterinary and Animal Sciences-Cover
  • ISSN: 1300-0128
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Molecular, cellular, and physiological determinants of bull fertility

Alexis Marie PARISI, Shannon Kate THOMPSON, Abdullah KAYA, Erdoğan MEMİLİ

Survivability of caprine oocytes vitrifed in conventional and open pulled straws

Rameez ALI, Waquar RAZZAQUE, Utsav SHARMA, Kafil HUSSAIN, Anil PANDEY

New understanding of an old phenomenon: uncontrolled factors and misconceptions that cast a shadow over studies of the ‘male effect’ on reproduction in small ruminants

Trina Jorre De St JORRE, Penny Alison Rhian HAWKEN, Graeme Bruce MARTIN

Investigation of the efficacy of Tarantula cubensis extract (Theranekron D6) in the treatment of subclinical and clinical mastitis in dairy cows

Kutlay GÜRBULAK, Aytaç AKÇAY, Kadir Semih GÜMÜŞSOY, Birgit SIST

Expression of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha during the periovulatory period in goats

Chainarong NAVANUKRAW, Jiratti THAMMASIRI, Tossapol MOONMANEE, Jaruk NATTHAKORNKUL

Endocrine and metabolic mechanisms of embryo and fetal intrauterine growth retardation in dairy cows

Anatoliy NEZHDANOV, Sergey SHABUNIN, Vitaliy MIKHALEV, Nikolay KLIMOV, Anton CHERNITSKIY

Usefulness of short sequence repeat markers in goat genetic diversity studies on the Asian and African continents

Faiz M. M. T. MARIKAR, Muneeb M. MUSTHAFA

Maternal embryokines that regulate development of the bovine preimplantation embryo

Peter James HANSEN, Anna Carolina DENICOL, Kyle Bradley DOBBS

The avian ovary and follicle development: some comparative and practical insights

Alan L. JOHNSON

Antioxidant supplementation and purification of semen for improved artificial insemination in livestock species

Peter PETRUSKA, Marcela CAPCAROVA, Peter SUTOVSKY